These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9360422)

  • 1. Haemostatic effects of iloprost in patients with lower limb ischemia.
    Trifiletti A; Scamardi R; Pizzoleo MA; Nevoso A; Soraci S; Bartolone S; Bagnato L; Barbera N
    Panminerva Med; 1997 Sep; 39(3):202-4. PubMed ID: 9360422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma prothrombotic markers after a short- and middle term treatment with iloprost in arteriopathic patients with critical limb ischemia.
    Ferlito S; Di Salvo MM; Attanasio L; Finocchiaro PM; Condorelli PM; Mazzone D
    Panminerva Med; 1994 Jun; 36(2):76-9. PubMed ID: 7530356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Iloprost infusion on metabolism in critical limb ischemia, utilizing microdialysis. A pilot study.
    Danielsson P; Metzsch C; Norgren L
    Int Angiol; 2004 Sep; 23(3):259-62. PubMed ID: 15765041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
    Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
    Duthois S; Cailleux N; Lévesque H
    J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient treatment of severe peripheral ischemia with intravenous intermittent low-dose iloprost. An open pilot study.
    Banyai S; Jenelten R; Wagner S; Allmann J; Banyai M; Koppensteiner R
    Int Angiol; 2002 Mar; 21(1):36-43. PubMed ID: 11941272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of iloprost in the treatment of critical ischemia of the limbs].
    Poggesi L; Comeglio M
    Ann Ital Med Int; 1993 Oct; 8 Suppl():71S-77S. PubMed ID: 7509614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Critical ischemia in elderly patients. Evaluation of the effect of two different methods of Iloprost therapy on the efficacy, tolerance, modification of quality of life and self-sufficiency].
    Cappelli R; Bicchi M; Arrigucci S; Boschi S; Guerrini M; Forconi S
    Minerva Cardioangiol; 1999 Mar; 47(3):81-8. PubMed ID: 10389449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization.
    Coppolino G; Buemi A; Bolignano D; Lacquaniti A; La Spada M; Stilo F; De Caridi G; Benedetto F; Loddo S; Buemi M; Spinelli F
    J Surg Res; 2009 Nov; 157(1):e129-35. PubMed ID: 19589539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with iloprost of critical ischemia of the lower limbs associated with cardiac insufficiency. Study of interaction with the pharmacokinetics of digoxin].
    Cabane J; Penin I; Bouslama K; Benchouieb A; Giral P; Picard O; Wattiaux MJ; Cheymol G; Souvignet G; Imbert JC
    Therapie; 1991; 46(3):235-40. PubMed ID: 1724327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and circulatory effects of Iloprost either administered for 1 week or 4 weeks in patients with peripheral obstructive arterial disease at Leriche-Fontaine stage III.
    Arosio E; Sardina M; Prior M; De Marchi S; Zannoni M; Bianchini C
    Eur Rev Med Pharmacol Sci; 1998; 2(2):53-9. PubMed ID: 10229559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavior of endothelin plasma levels during iloprost infusion in patients with severe ischemia in the lower extremities].
    Battistelli S; Borgogni T; Gori S; Manasse G
    Minerva Cardioangiol; 1995 Jun; 43(6):257-62. PubMed ID: 7566538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is transcutaneous oxygen and carbon dioxide monitoring indispensable in short- and long-term therapeutic management of non-reconstructable lower critical limb ischemia?
    Melillo E; Nuti M; Pedrinelli R; Buttitta F; Balbarini A
    Minerva Cardioangiol; 2006 Aug; 54(4):481-98. PubMed ID: 17016419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis.
    Di Salvo MM; Ardita G; Giani L; Mugno F; Stevenazzi F; Mazzone A
    Minerva Cardioangiol; 2006 Jun; 54(3):377-81. PubMed ID: 16733512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and haemostatic effects of intravenous prostaglandin E1 therapy in patients with peripheral arterial occlusive disease.
    Trifiletti A; Scamardi R; Pizzoleo MA; Sottilotta G; Soraci S; Attinà A; Bagnato L; Barbera N
    Panminerva Med; 1999 Mar; 41(1):15-7. PubMed ID: 10230250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Iloprost in the treatment of ischemic tissue lesions in diabetics. Results of a placebo-controlled multicenter study with a stable prostacyclin derivative].
    Brock FE; Abri O; Baitsch G; Bechara G; Beck K; Corovic D; Diehm C; Marshall M; Rahmel B; Scheffler P
    Schweiz Med Wochenschr; 1990 Oct; 120(40):1477-82. PubMed ID: 1699272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemostatic changes in patients with deep vein thrombosis.
    Trifiletti A; Scamardi R; Pizzoleo MA; Soraci S; Nevoso A; Bagnato L; Barbera N
    Panminerva Med; 1997 Mar; 39(1):21-3. PubMed ID: 9175416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it possible to improve outcome in patients undergoing surgery for acute limb ischemia? Can iloprost, a prostacyclin analogue, be helpful?
    de Donato G; Gussoni G; de Donato G
    Chir Ital; 2004; 56(6):769-80. PubMed ID: 15771029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a conservative treatment with iloprost in severe peripheral occlusive arterial disease (POAD). GISAP Study.
    Int Angiol; 1994 Mar; 13(1):70-4. PubMed ID: 7521384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.